With that in mind, let's take a closer look at WellPoint and see what CAPS investors are saying about the stock right now.
Managed health care
Interim CEO John Cannon
Return on Equity (average, past 3 years)
$22.1 billion / $14.3 billion
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 94% of the 1,006 members who have rated WellPoint believe the stock will outperform the S&P 500 going forward.
Got to say that I really like and agree with the analysis I've read about this one. Strong competitive advantages (scale, stickiness, network effect) that have been overshadowed by fixable management missteps and uncertainty. Significantly undervalued.
What's inside Supernova?
If you're an investor looking for big long-term winners, Motley Fool co-founder David Gardner's picks have frequently trounced the market. How? Because he's always on the lookout for revolutionary stocks and recommends them before Wall Street catches on to their disruptive potential. If you're interested in how David discovers his winners, click here to get instant access to a personal tour behind David's Supernova service.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
The article Why WellPoint Is Ready to Recover originally appeared on Fool.com.
Fool contributor Brian Pacampara has no position in any stocks mentioned. The Motley Fool recommends UnitedHealth Group and WellPoint. The Motley Fool owns shares of WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.